RU97110218A - 6-METHOXY-1H-BENZOTRIAZOLE-5-CARBOXAMIDE DERIVATIVES, METHODS FOR PRODUCING THERE AND THEIR PHARMACEUTICAL COMPOSITIONS - Google Patents
6-METHOXY-1H-BENZOTRIAZOLE-5-CARBOXAMIDE DERIVATIVES, METHODS FOR PRODUCING THERE AND THEIR PHARMACEUTICAL COMPOSITIONSInfo
- Publication number
- RU97110218A RU97110218A RU97110218/04A RU97110218A RU97110218A RU 97110218 A RU97110218 A RU 97110218A RU 97110218/04 A RU97110218/04 A RU 97110218/04A RU 97110218 A RU97110218 A RU 97110218A RU 97110218 A RU97110218 A RU 97110218A
- Authority
- RU
- Russia
- Prior art keywords
- ethyl
- benzotriazole
- methoxy
- acid addition
- pharmaceutically acceptable
- Prior art date
Links
- RPAHKVOVIOEJND-UHFFFAOYSA-N 6-methoxy-2H-benzotriazole-5-carboxamide Chemical class C1=C(C(N)=O)C(OC)=CC2=C1N=NN2 RPAHKVOVIOEJND-UHFFFAOYSA-N 0.000 title claims 5
- 239000008194 pharmaceutical composition Substances 0.000 title claims 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 11
- 239000002253 acid Substances 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 9
- 239000011780 sodium chloride Substances 0.000 claims 9
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 6
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 6
- 229910052799 carbon Inorganic materials 0.000 claims 5
- 125000004432 carbon atoms Chemical group C* 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- 239000004480 active ingredient Substances 0.000 claims 3
- 125000003368 amide group Chemical group 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 125000006239 protecting group Chemical group 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 210000001035 Gastrointestinal Tract Anatomy 0.000 claims 1
- 230000003474 anti-emetic Effects 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 230000000875 corresponding Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000002708 enhancing Effects 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 238000007327 hydrogenolysis reaction Methods 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
Claims (11)
[в которой R1 обозначает этил или циклопропилметил,
R2 обозначает атом водорода, метил или этил,
n равно 1, 2 или 3 и
волнистая линия означает, что конфигурация заместителей на атоме углерода, связанном с атомом азота в амидной группе, является RS, R или S], или его фармацевтически приемлемые аддитивные кислые соли.1. Derived 6-methoxy-1H-benzotriazole-5-carboxamide of the General formula (I)
[in which R 1 denotes ethyl or cyclopropylmethyl,
R 2 represents a hydrogen atom, methyl or ethyl,
n is 1, 2 or 3 and
wavy line means that the configuration of the substituents on the carbon atom bonded to the nitrogen atom in the amide group is RS, R or S], or its pharmaceutically acceptable acid addition salts.
[в которой R1 обозначает этил или циклопропилметил,
R2 обозначает атом водорода, метил или этил,
n равно 1, 2 или 3 и
волнистая линия означает, что конфигурация заместителей на углеродном атоме, связанном N-атомом в амидной группе, является RS, R или S],
или его фармацевтически приемлемой аддитивной кислой соли, и фармацевтически приемлемый носитель.6. A pharmaceutical composition having antiemetic activity and activity enhancing the contractility of the gastrointestinal tract, characterized in that it includes as an active ingredient an effective amount of a 6-methoxy-1H-benzotriazole-5-carboxamide derivative of the general formula (I):
[in which R 1 denotes ethyl or cyclopropylmethyl,
R 2 represents a hydrogen atom, methyl or ethyl,
n is 1, 2 or 3 and
wavy line means that the configuration of the substituents on the carbon atom bonded to the N atom in the amide group is RS, R or S],
or a pharmaceutically acceptable acid addition salt thereof, and a pharmaceutically acceptable carrier.
[в которой R1 обозначает этил или циклопропилметил,
R2 обозначает атом водорода, метил или этил,
n равно 1, 2 или 3 и
волнистая линия означает, что конфигурация заместителей на углеродном атоме, связанном с атомом азота в амидном радикале, является RS, R или S]
или его фармацевтически приемлемой кислой аддитивной соли, включающий взаимодействие соединения, представленного формулой (III):
(в которой R2a обозначает водород, метил, этил или аминозащитную группу)
или его реакционноспособного производного с соединением, представленным формулой (IV):
[в которой R1 обозначает этил или циклопропилметил,
n равно 1, 2 или 3 и
волнистая линия означает, что конфигурация заместителей на атоме углерода, связанном с N-атомом амидной группы, является RS, R или S]
и когда в качестве одного из реагентов используют соединение формулы (III), в котором R2a обозначает амино-защитную группу, превращают R2a в соответствующем продукте в атом водорода путем гидролиза или гидрогенолиза названного продукта и, при необходимости, превращают полученный продукт в его фармацевтически приемлемую кислую аддитивную соль.9. A method of obtaining a 6-methoxy-1H-benzotriazole-5-carboxamide derivative represented by the formula (I):
[in which R 1 denotes ethyl or cyclopropylmethyl,
R 2 represents a hydrogen atom, methyl or ethyl,
n is 1, 2 or 3 and
wavy line means that the configuration of the substituents on the carbon atom bonded to the nitrogen atom in the amide radical is RS, R or S]
or a pharmaceutically acceptable acid addition salt thereof, comprising reacting a compound represented by formula (III):
(in which R 2a is hydrogen, methyl, ethyl or an amino protecting group)
or its reactive derivative with a compound represented by formula (IV):
[in which R 1 denotes ethyl or cyclopropylmethyl,
n is 1, 2 or 3 and
wavy line means that the configuration of the substituents on the carbon atom bonded to the N atom of the amide group is RS, R or S]
and when a compound of formula (III) in which R 2a is an amino protecting group is used as one of the reagents, R 2a in the corresponding product is converted to a hydrogen atom by hydrolysis or hydrogenolysis of the product and, if necessary, the resulting product is converted into its pharmaceutically acceptable acid addition salt.
[в которой R1 обозначает этил или циклопропилметил,
R3 обозначает аминозащитную группу,
n равно 1, 2 или 3 и
волнистая линия означает, что конфигурация заместителей на углеродном атоме, связанном с N-атомом в амидном радикале, является RS, R или S], или его кислая аддитивная соль.10. Derived 6-methoxy-1H-benzotriazole-5-carboxamide of the formula (II):
[in which R 1 denotes ethyl or cyclopropylmethyl,
R 3 denotes an amino protecting group,
n is 1, 2 or 3 and
wavy line means that the configuration of the substituents on the carbon atom bonded to the N atom in the amide radical is RS, R or S], or its acid addition salt.
(в которой R1 обозначает этил или циклопропилметил) или его кислая аддитивная соль.11. The derivative of (R) -3-amino-1H-hexahydroazepine of the formula (IVb):
(in which R 1 is ethyl or cyclopropylmethyl) or an acid addition salt thereof.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP312,673/1994 | 1994-11-21 | ||
JP31267394 | 1994-11-21 | ||
PCT/JP1995/002310 WO1996016059A1 (en) | 1994-11-21 | 1995-11-13 | 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
RU97110218A true RU97110218A (en) | 1999-05-20 |
RU2141958C1 RU2141958C1 (en) | 1999-11-27 |
Family
ID=18032051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU97110218/04A RU2141958C1 (en) | 1994-11-21 | 1995-11-13 | Derivatives of 6-methoxy-1h-benzotriazole-5-carboxamide, method of their synthesis and pharmaceutical composition containing thereof |
Country Status (28)
Country | Link |
---|---|
US (1) | US5932568A (en) |
EP (1) | EP0794184B1 (en) |
KR (1) | KR100382998B1 (en) |
CN (1) | CN1070859C (en) |
AR (1) | AR001998A1 (en) |
AT (1) | ATE201679T1 (en) |
AU (1) | AU695490B2 (en) |
BR (1) | BR9509800A (en) |
CA (1) | CA2205523A1 (en) |
CZ (1) | CZ285535B6 (en) |
DE (1) | DE69521142T2 (en) |
DK (1) | DK0794184T3 (en) |
ES (1) | ES2156950T3 (en) |
FI (1) | FI972129A (en) |
GR (1) | GR3036226T3 (en) |
HK (1) | HK1001395A1 (en) |
HU (1) | HUT77316A (en) |
IL (1) | IL116012A (en) |
MX (1) | MX9703712A (en) |
NO (1) | NO312763B1 (en) |
NZ (1) | NZ295259A (en) |
PL (1) | PL182361B1 (en) |
PT (1) | PT794184E (en) |
RU (1) | RU2141958C1 (en) |
SK (1) | SK282600B6 (en) |
TW (1) | TW419478B (en) |
WO (1) | WO1996016059A1 (en) |
ZA (1) | ZA959825B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5714601A (en) * | 2000-04-19 | 2001-10-30 | Univ Johns Hopkins | Methods for prevention and treatment of gastrointestinal disorders |
AU2003291342A1 (en) * | 2002-11-05 | 2004-06-07 | Arena Pharmaceuticals, Inc. | Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof |
CA2818925A1 (en) * | 2010-11-24 | 2012-05-31 | Stemergie Biotechnology Sa | Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5925785B2 (en) * | 1976-01-01 | 1984-06-21 | 山之内製薬株式会社 | Novel carboxylic acid amide derivative |
JPS52100473A (en) * | 1976-02-20 | 1977-08-23 | Yamanouchi Pharmaceut Co Ltd | Novel azimidebenzamide derivative and its production |
JPH02104572A (en) * | 1988-10-13 | 1990-04-17 | Dainippon Pharmaceut Co Ltd | Benzoic acid amide derivative |
-
1995
- 1995-11-13 CN CN95197383A patent/CN1070859C/en not_active Expired - Fee Related
- 1995-11-13 SK SK615-97A patent/SK282600B6/en unknown
- 1995-11-13 US US08/849,415 patent/US5932568A/en not_active Expired - Fee Related
- 1995-11-13 ES ES95936779T patent/ES2156950T3/en not_active Expired - Lifetime
- 1995-11-13 CZ CZ971540A patent/CZ285535B6/en not_active IP Right Cessation
- 1995-11-13 DK DK95936779T patent/DK0794184T3/en active
- 1995-11-13 KR KR1019970703418A patent/KR100382998B1/en not_active IP Right Cessation
- 1995-11-13 PT PT95936779T patent/PT794184E/en unknown
- 1995-11-13 RU RU97110218/04A patent/RU2141958C1/en not_active IP Right Cessation
- 1995-11-13 HU HU9701902A patent/HUT77316A/en unknown
- 1995-11-13 AU AU38563/95A patent/AU695490B2/en not_active Ceased
- 1995-11-13 BR BR9509800A patent/BR9509800A/en not_active Application Discontinuation
- 1995-11-13 CA CA002205523A patent/CA2205523A1/en not_active Abandoned
- 1995-11-13 NZ NZ295259A patent/NZ295259A/en unknown
- 1995-11-13 DE DE69521142T patent/DE69521142T2/en not_active Expired - Fee Related
- 1995-11-13 MX MX9703712A patent/MX9703712A/en active IP Right Grant
- 1995-11-13 PL PL95320294A patent/PL182361B1/en unknown
- 1995-11-13 AT AT95936779T patent/ATE201679T1/en not_active IP Right Cessation
- 1995-11-13 EP EP95936779A patent/EP0794184B1/en not_active Expired - Lifetime
- 1995-11-13 WO PCT/JP1995/002310 patent/WO1996016059A1/en active IP Right Grant
- 1995-11-16 IL IL11601295A patent/IL116012A/en active IP Right Grant
- 1995-11-20 ZA ZA959825A patent/ZA959825B/en unknown
- 1995-11-20 TW TW084112307A patent/TW419478B/en not_active IP Right Cessation
- 1995-11-21 AR ARP950100242A patent/AR001998A1/en unknown
-
1997
- 1997-05-07 NO NO19972111A patent/NO312763B1/en not_active IP Right Cessation
- 1997-05-19 FI FI972129A patent/FI972129A/en unknown
-
1998
- 1998-01-10 HK HK98100217A patent/HK1001395A1/en not_active IP Right Cessation
-
2001
- 2001-07-13 GR GR20010401078T patent/GR3036226T3/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2215013A1 (en) | N-substituted indol-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action | |
KR920008065A (en) | Peptide Compounds, Methods For Making Them, And Pharmaceutical Compositions Containing Them | |
HUT34160A (en) | Process for producing of optically active carbosole preparates and medical preparates consisting of them | |
EP0747383A3 (en) | Polyamine salts of clavulanic acid | |
EP0353955A3 (en) | Novel compounds | |
HUT64842A (en) | Method for producing pharmaceutical preparatives containing 2-[n-(2-amino-ethyl)-amino]-acetic acid derivatives | |
CA2152137A1 (en) | Phenyl-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them | |
KR900018006A (en) | Phenolic Derivatives for the Promotion of Human Nerve Growth Factors | |
IE830310L (en) | 1,2,5-trisubstituted pyrroles | |
CA2234319A1 (en) | Fluoro-substituted adamantane derivatives | |
EP0884326A3 (en) | Antithrombitic compound | |
RU97110218A (en) | 6-METHOXY-1H-BENZOTRIAZOLE-5-CARBOXAMIDE DERIVATIVES, METHODS FOR PRODUCING THERE AND THEIR PHARMACEUTICAL COMPOSITIONS | |
RU98103388A (en) | (R) -5-BROM-N- (1-ETHYL-4-Methylhexagidro-1H-1,4-Diazepin-6-IL) -2-METHOXI-6-M COMPOSITION CONTAINING THE SPECIFIED CONNECTION | |
EP0930292A4 (en) | Process for preparing beta-amino-alpha-hydroxy acid derivatives | |
EP0343801A3 (en) | N-(5,6,7,8-tetrahydropyrido(2,3-d)pyrimidin-6-yl-alkanoyl)-glutamic acid derivatives | |
HUT68190A (en) | Process for producing ergoline derivatives of serotoninergic activity | |
KR960029312A (en) | N-arylalkylphenylacetamide derivatives and preparation methods thereof | |
IE780901L (en) | Tetrazolyl-piperidinyl amides | |
RU99109978A (en) | BIS (AKRIDINKARBOXAMID) and BIS (PHENASINCARBOXAMID), USEFUL AS ANTICOPODUS AGENTS | |
EP0318859A3 (en) | N-substituted mercaptopropanamide derivatives | |
ATE92927T1 (en) | 1-CARBOXY-1-VINYLOXYIMINOAMINOTHIAZOLCEPHALOSPORIN DERIVATIVES AND THEIR PREPARATION. | |
ES8601099A1 (en) | Derivatives of n-(methoxyphenacyl)amine, their therapeutical use and process for their preparation | |
NO840732L (en) | ANALOGY PROCEDURE FOR PREPARING THE THERAPEUTIC ACTIVE COMPOUND N- (3-TRIFLUORMETHYLPHENYL) -N'-PROPARGYLPIPERAZINE | |
AU530930B2 (en) | Pharmaceutical compositions and method of treating heart disease | |
KR920002594A (en) | 5-isothiazolamine derivative |